These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24093083)

  • 1. Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.
    Roher AE; Maarouf CL; Malek-Ahmadi M; Wilson J; Kokjohn TA; Daugs ID; Whiteside CM; Kalback WM; Macias MP; Jacobson SA; Sabbagh MN; Ghetti B; Beach TG
    Am J Neurodegener Dis; 2013; 2(3):187-207. PubMed ID: 24093083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations.
    Maarouf CL; Daugs ID; Spina S; Vidal R; Kokjohn TA; Patton RL; Kalback WM; Luehrs DC; Walker DG; Castaño EM; Beach TG; Ghetti B; Roher AE
    Mol Neurodegener; 2008 Nov; 3():20. PubMed ID: 19021905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative changes in human γ-secretase underlie familial Alzheimer's disease.
    Szaruga M; Veugelen S; Benurwar M; Lismont S; Sepulveda-Falla D; Lleo A; Ryan NS; Lashley T; Fox NC; Murayama S; Gijsen H; De Strooper B; Chávez-Gutiérrez L
    J Exp Med; 2015 Nov; 212(12):2003-13. PubMed ID: 26481686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer's Disease.
    Kabir MT; Uddin MS; Setu JR; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Neurotox Res; 2020 Dec; 38(4):833-849. PubMed ID: 32556937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease.
    Weggen S; Beher D
    Alzheimers Res Ther; 2012 Mar; 4(2):9. PubMed ID: 22494386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Pimenova AA; Goate AM
    Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease.
    Littau JL; Velilla L; Hase Y; Villalba-Moreno ND; Hagel C; Drexler D; Osorio Restrepo S; Villegas A; Lopera F; Vargas S; Glatzel M; Krasemann S; Quiroz YT; Arboleda-Velasquez JF; Kalaria R; Sepulveda-Falla D
    Brain Pathol; 2022 Nov; 32(6):e13097. PubMed ID: 35695802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting γ-Secretase for Familial Alzheimer's Disease.
    Wolfe MS
    Med Chem Res; 2021 Jul; 30(7):1321-1327. PubMed ID: 35295247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer's Disease Patients.
    Dinkel F; Trujillo-Rodriguez D; Villegas A; Streffer J; Mercken M; Lopera F; Glatzel M; Sepulveda-Falla D
    Front Aging Neurosci; 2020; 12():220. PubMed ID: 32848702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
    Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
    Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction.
    Hata S; Fujishige S; Araki Y; Taniguchi M; Urakami K; Peskind E; Akatsu H; Araseki M; Yamamoto K; Martins RN; Maeda M; Nishimura M; Levey A; Chung KA; Montine T; Leverenz J; Fagan A; Goate A; Bateman R; Holtzman DM; Yamamoto T; Nakaya T; Gandy S; Suzuki T
    Ann Neurol; 2011 Jun; 69(6):1026-31. PubMed ID: 21681798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Alzheimer's Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds.
    Veugelen S; Saito T; Saido TC; Chávez-Gutiérrez L; De Strooper B
    Neuron; 2016 Apr; 90(2):410-6. PubMed ID: 27100199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.
    Portelius E; Andreasson U; Ringman JM; Buerger K; Daborg J; Buchhave P; Hansson O; Harmsen A; Gustavsson MK; Hanse E; Galasko D; Hampel H; Blennow K; Zetterberg H
    Mol Neurodegener; 2010 Jan; 5():2. PubMed ID: 20145736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides.
    Stokin GB; Almenar-Queralt A; Gunawardena S; Rodrigues EM; Falzone T; Kim J; Lillo C; Mount SL; Roberts EA; McGowan E; Williams DS; Goldstein LS
    Hum Mol Genet; 2008 Nov; 17(22):3474-86. PubMed ID: 18694898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage.
    Zhang C; Browne A; Kim DY; Tanzi RE
    Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.